CLINICAL SPECTRUM TIME COURSE IN NON ANTI JO-1 POSITIVE ANTISYNTHETASE SYNDROME

被引：1

作者：

Cavagna, L. ^{[1
,2
]}

Andersson, H. ^{[3
]}

Gonazlez-Gay, M. A. ^{[4
]}

Molberg, O. ^{[3
]}

Franceschini, F. ^{[5
,6
]}

Cavazzana, I. ^{[5
,6
]}

Castaneda, S. ^{[7
]}

Lopez Longo, F. J. ^{[8
]}

Balduzzi, S. ^{[1
,2
]}

Montecucco, C. ^{[1
,2
]}

Triantafyllias, K. ^{[9
]}

Weinmann-Menke, J. ^{[10
]}

Rojas-Serrano, J. ^{[11
,12
]}

Sifuentes Giraldo, A. ^{[13
]}

Bachiller-Corral, J. ^{[13
]}

Salaffi, F. ^{[14
,15
]}

Iannone, F. ^{[16
]}

Giannini, M. ^{[16
]}

Nuno, L. ^{[17
]}

Bonella, F. ^{[18
]}

Costabel, U. ^{[18
]}

Parisi, S. ^{[19
]}

Selmi, C. ^{[20
]}

Scirse, C. ^{[21
]}

Benucci, M. ^{[22
]}

Doria, A. ^{[23
]}

Caporali, R. ^{[1
,2
]}

Perez-Roman, I. ^{[11
,12
]}

Ghirardello, A. ^{[23
]}

机构：

[1] Univ Pavia, Rheumatol, Pavia, Italy

[2] Irccs Found Policlin S Matteo, Pavia, Italy

[3] Univ Hosp, Rheumatol, Oslo, Norway

[4] Hosp Univ Marques de Valdecilla, Rheumatol, Santander, Spain

[5] Univ Brescia, Rheumatol, Brescia, Italy

[6] AO Spedali Civili, Brescia, Italy

[7] Hosp Univ Princesa, Rheumatol, Madrid, Spain

[8] Hosp Gen Univ G Maranon, Rheumatol, Madrid, Spain

[9] ACURA Ctr, Rheumatol, Bad Kreuznach, Germany

[10] Univ Hosp J Gutenberg, Rheumatol, Mainz, Germany

[11] Inst Nacl Enfermedades Resp, ILD Unit, Tlalpan, Mexico

[12] Inst Nacl Enfermedades Resp, Rheumatol Unit, Tlalpan, Mexico

[13] Univ Hosp Ramon & Cajal, Rheumatol, Madrid, Spain

[14] Univ Marche, Rheumatol, Jesi, Italy

[15] C Urbani Hosp, Jesi, Italy

[16] Univ Bari, Rheumatol, Bari, Italy

[17] Hosp Univ La Paz, Rheumatol, Madrid, Spain

[18] Univ Duisburg Essen, Univ Hosp, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Essen, Germany

[19] Citta Salute & Sci, Rheumatol, Turin, Italy

[20] Humanitas Res Hosp, Rheumatol, Rozzano, Italy

[21] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy

[22] Nuovo Osp S Giovanni Dio, Rheumatol, Florence, Italy

[23] Univ Padua, Rheumatol, Padua, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.2205

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0291

引用

页码：540 / 541

页数：2

共 50 条

[21] Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin
Dawson, JK
Abernethy, VE
Lynch, MP
BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (01): : 144 - 145
[22] Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies
Scire, Carlo Alberto
Gonzalez-Gay, Miguel A.
Selva-O'Callaghan, Albert
Cavagna, Lorenzo
RESPIRATORY MEDICINE, 2017, 132 : 265 - 266
[23] IDIOPATHIC INFLAMMATORY MYOPATHY OF THE ANTISYNTHETASE (JO-1) TYPE ASSOCIATED WITH NONCASEATING GRANULOMAS
MODER, KG
GAFFEY, TA
MATTESON, EL
ARTHRITIS AND RHEUMATISM, 1993, 36 (12): : 1743 - 1747
[24] Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Aggarwal, Rohit
Cassidy, Elaine
Fertig, Noreen
Koontz, Diane Carol
Lucas, Mary
Ascherman, Dana P.
Oddis, Chester V.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 227 - 232
[25] Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Hervier, Baptiste
Devilliers, Herve
Benveniste, Olivier
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) : E18 - E18
[26] Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin
Tellus, MM
Buchanan, RRC
BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (12): : 1187 - 1188
[27] CLINICAL SPECTRUM TIME COURSE COMPARISON BETWEEN PL-7, PL-12 AND EJ POSITIVE ANTISYNTHETASE SYNDROME
Trallero Araguas, E.
Selva O'Callaghan, A.
Scire, C. A.
Codullo, V.
Castaneda, S.
Ortego Centeno, N.
Pereira da Silva, J. A.
Fiehn, C.
Schwarting, A.
Manfredi, A.
Emmi, G.
Barsotti, S.
Molberg, O.
Doria, A.
Parisi, S.
Scarpato, S.
Pipitone, N.
Piga, M.
Cavazzana, I.
Lopez-Longo, F. J.
Bachiller-Corral, J.
Benucci, M.
Rojas-Serrano, J.
Triantafyllias, K.
Perez-Gomez, N.
Cagnotto, G.
Maurier, F.
Quartuccio, L.
Bartoloni Bocci, E.
Tomietto, P.
Caporali, R.
Iannone, F.
Gonzalez-Gay, M. A.
Cavagna, L.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1272 - 1273
[28] Rituximab in the Treatment of Jo-1 Antibody-Associated Antisynthetase Syndrome: Anti-Ro52 Positivity As a Marker for Severity and Treatment Response
Bauhammer, Jutta
Blank, Norbert
Lorenz, Hanns-Martin
Max, Regina
Krause, Dietmar
Fiehn, Christoph
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[29] Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome
Valle, Luca
Katz, James
Duffy, Austin
Hueman, Matthew
Wang, Hao-Wei
Hughes, Marybeth
Sissung, Tristan
Figg, William
Citrin, Deborah
BJR CASE REPORTS, 2022, 8 (03):
[30] Relationship between Jo-1 B Cell Epitope Profile and Clinical Features of Anti-Synthetase Syndrome
Yamaguchi, Koichi
Tang, Qi
Laconti, Joseph J.
Kippelen, Fanny
Zhu, Lei
Poland, Paul
Hartoyo, Mara
Aggarwal, Rohit
Oddis, Chester V.
Ascherman, Dana P.
ACR OPEN RHEUMATOLOGY, 2024, 6 (10) : 615 - 624

← 1 2 3 4 5 →